(Q38136296)

29 August 2017

title

The evolving history of influenza viruses and influenza vaccines (English)

1 reference

29 August 2017

Claude Hannoun

1

1 reference

29 August 2017

publication date

12 September 2013

1 reference

Expert Review of Vaccines

29 August 2017

published in

1 reference

29 August 2017

volume

12

1 reference

29 August 2017

issue

9

1 reference

29 August 2017

page(s)

1085-1094

1 reference

A Virus Obtained from Influenza Patients

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

Effect of test system on the ability of monoclonal antibodies to detect antigenic drift in influenza A(H1N1) virus haemagglutinins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

Protective Effect of Vaccination Against Induced Influenza A

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

PROTECTIVE EFFECT OF VACCINATION AGAINST INDUCED INFLUENZA B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

THE PREPARATION AND PROPERTIES OF INFLUENZA VIRUS VACCINES CONCENTRATED AND PURIFIED BY DIFFERENTIAL CENTRIFUGATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

Productivity, apoptosis, and infection dynamics of influenza A/PR/8 strains and A/PR/8-based reassortants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

Towards universal influenza vaccines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

A SIMPLIFIED PROCEDURE FOR THE CONCENTRATION AND PURIFICATION OF INFLUENZA VIRUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

AN EVALUATION OF METHODS FOR THE CONCENTRATION AND PURIFICATION OF INFLUENZA VIRUS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

The annual production cycle for influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

Mapping the antigenic and genetic evolution of influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

The coming era of quadrivalent human influenza vaccines: who will benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

The need for quadrivalent vaccine against seasonal influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

The rationale for quadrivalent influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

Challenge of conducting a placebo-controlled randomized efficacy study for influenza vaccine in a season with low attack rate and a mismatched vaccine B strain: a concrete example

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

Detection and characterization of new influenza B virus variants in 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

Epidemiology of human influenza A and B viruses in Myanmar from 2005 to 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

Virologically confirmed population-based burden of hospitalization caused by influenza A and B among children in Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

The economic value of a quadrivalent versus trivalent influenza vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

Universal influenza vaccination in the United States: are we ready? Report of a meeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

The burden of influenza B: a structured literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.2013.824709

10.1586/14760584.2013.824709

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference